St. Jude Medical could be facing a rocky road this year. The Little Canada, MN–based maker of heart failure devices and more recently announced an earnings forecast that fell behind what analysts were predicting for the company.
Earnings could fall in the range of $3.95 to $4.05 per share, St. Jude announced Wednesday. Analysts at had been expecting around $4.18 per share on average, according to the Thomson Financial Network.
For the fourth quarter ended January 2, the company earned $113 million off $1.45 billion in sales, versus $245 million in profits off $1.44 billion in sales a year before. For the full year, the company earned $880 million off $5.54 billion in sales, versus $1.00 billion in profits off $5.62 billion in sales a year before.
